Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells
John T. Walker(Vanderbilt University), Marcela Briššová(Vanderbilt University Medical Center), Matthew Ishahak(University of Miami), Conrad Reihsmann(Vanderbilt University Medical Center), Rachana Haliyur(Vanderbilt University), Gregory Poffenberger(Vanderbilt University Medical Center), Heather A. Nelson(SUNY Upstate Medical University), Joseph R. Luchsinger(Vanderbilt University), Alvin C. Powers(Vanderbilt University Medical Center), Rita Bottino(Children's Hospital of Pittsburgh), Diane C. Saunders(Vanderbilt University Medical Center), Ashutosh Agarwal(University of Miami), Peng Wang(Icahn School of Medicine at Mount Sinai), Radhika Aramandla(Vanderbilt University Medical Center), Adolfo Garcı́a-Ocaña(City of Hope)
Cited by 58
Related Papers
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Microfluidic heart on a chip for higher throughput pharmacological studies
|Lab on a Chip|2013|490
Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
|Journal of Biological Chemistry|2002|379
Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues
|Biomaterials|2014|237